Menopause & midlife

AMH and Menopause Timing: What the Test Predicts

Save

An AMH test measures your remaining ovarian reserve and falls as menopause nears, so a low result points toward an earlier transition. But it cannot predict the exact year your periods will end: for any individual the estimate carries years of uncertainty. AMH is a rough guide, not a precise menopause countdown.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What does an AMH test measure?

AMH is a hormone released by the small, immature follicles in your ovaries, so its level mirrors the size of your remaining egg pool, known as ovarian reserve. As that pool shrinks with age, AMH steadily falls, becoming very low in the 1 to 2 years before the final period 1. According to reproductive medicine guidelines, AMH is one of the more stable markers of ovarian reserve, because it varies less across the cycle than FSH does 1. What AMH does not measure is egg quality or your ability to conceive on any given cycle, which depends on far more than follicle count. It counts the eggs remaining, not their odds of success.

Can AMH predict when menopause will happen?

AMH can nudge an estimate of menopause timing, but it cannot forecast the exact year for an individual. Across large groups, women with lower AMH for their age tend to reach menopause sooner, so researchers can model average timing 2. For one person, though, the prediction spans a wide window, often several years, because the pace of ovarian decline varies and no single value captures it 1. Reproductive medicine guidance specifically cautions against using AMH to counsel a woman about her personal reproductive lifespan or exact menopause date 1. The NICE guideline likewise advises against using AMH to diagnose menopause 3. Because menopause itself is only confirmed 12 months after the final period, even a well-informed estimate stays a probability, not an appointment 2.

When is an AMH test worth doing?

AMH testing is most valuable when a concrete decision hangs on it, rather than for general reassurance. It helps guide fertility planning, for instance weighing the best age to freeze eggs or predicting how ovaries may respond to IVF stimulation 1. A very low AMH in a younger woman can also flag diminished ovarian reserve or, with an elevated FSH, primary ovarian insufficiency before age 40 4. Understanding how age affects fertility alongside AMH gives a fuller picture than the number alone, and pairing it with a good AMH number for fertility helps set realistic expectations.

How does AMH change across life stages?

AMH traces a rising-then-falling curve across a woman's life, which is why age frames every result. It climbs through adolescence, peaks in the early-to-mid 20s, then declines gradually until it becomes undetectable around menopause 1. A low AMH therefore means something different at 25 than at 48: in a younger woman it may prompt questions about diagnosing perimenopause or early ovarian aging, while near midlife it simply confirms the expected trend. Because the whole curve shifts earlier or later from woman to woman, the same AMH value maps onto different likely timelines depending on when in life it is measured 2.

When a clinician helps make sense of AMH

A clinician can translate an AMH result into what it means for your goals, whether that is conceiving now, preserving future options, or understanding your menopause timeline. Because one number carries so much uncertainty, they weigh it against your age, cycle history, and other tests rather than reading it in isolation. This matters most when fertility decisions are time-sensitive or when a strikingly low result appears at a young age. Gale can help you prepare questions for that conversation.

Common questions

No. AMH can suggest whether menopause is likely to come earlier or later than average, but for any individual the estimate carries years of uncertainty. It cannot fix a date.

A low AMH suggests a smaller remaining egg supply for your age and, on average, points toward an earlier menopause. It does not set a date, and it is interpreted alongside your age and cycle history rather than alone.

AMH measures egg quantity, or reserve, not egg quality or your monthly odds of conceiving. It is used mainly in fertility planning and to predict how ovaries may respond to IVF stimulation.

Guidelines do not recommend AMH just to diagnose or date menopause, because it predicts timing only roughly. It is more useful for time-sensitive fertility decisions, which a clinician can help you weigh.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When AMH results need clinical context

  • —A very low AMH with menopause symptoms before age 40 is a reason to seek clinician review for possible primary ovarian insufficiency.
  • —Absent periods for several months outside of pregnancy are a reason to seek clinician review.
  • —A hormone result that conflicts with your symptoms or plans is a reason to seek clinician review rather than to self-interpret.
  • —Time-sensitive fertility concerns are a reason to seek prompt clinician review.

This article is general health education, not a fertility or menopause prognosis. A gynecologist or reproductive endocrinologist is the clinician who can interpret what an AMH result means for an individual.

References

  1. 1.Practice Committee of the American Society for Reproductive Medicine (2020). Testing and interpreting measures of ovarian reserve: a committee opinion. Fertility and Sterility. doi:10.1016/j.fertnstert.2020.09.134 ✓AMH reflects ovarian reserve, is more stable across the cycle than FSH, predicts ovarian response to stimulation, and should not be used to counsel about natural fertility or precise menopause timing for an individual
  2. 2.Harlow SD, Gass M, Hall JE, et al. / STRAW+10 Collaborative Group (2012). Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging. Menopause. doi:10.1097/gme.0b013e31824d8f40 ✓Declining AMH and antral follicle count accompany the stages of reproductive aging, allowing population-level modeling of menopause timing
  3. 3.National Institute for Health and Care Excellence (2026). Menopause: identification and management (NG23). National Institute for Health and Care Excellence (NICE). link ✓NICE does not recommend anti-Mullerian hormone testing to diagnose menopause or perimenopause
  4. 4.Webber L, et al. (ESHRE) (2016). ESHRE Guideline: management of women with premature ovarian insufficiency. Human Reproduction. doi:10.1093/humrep/dew027 ✓Very low or undetectable AMH accompanies diminished ovarian reserve and, with elevated FSH and menstrual disturbance, primary ovarian insufficiency before age 40

4 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library